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Ethnopharmacological relevance: Tithonia diversifolia (Hemsl.) A. Gray has been commonly used in folk
medicine to treat abscesses, microbiological infections, snake bites, malaria and diabetes. Both anti-
inﬂammatory and anti-malarial properties have been identiﬁed using appropriate assays, but the
effective doses have demonstrated toxic effects for the experimental animals. Most of the pharmaco-
logical activities have been attributed to sesquiterpene lactones (STLs) and some chlorogenic acid
derivatives (CAs) in the leaves of this species. This work aimed to evaluate the repeated-dose toxicity of
an aqueous extract (AE) from Tithonia diversifolia leaves and to compare the results with an extract rich in
STLs (LRE) and a polar extract (PE) without STLs but rich in CAs. The purpose of this work was to provide
insights into the identity of the compounds responsible for the toxic effects of Tithonia diversifolia.
Materials and methods: The major classes of compounds were conﬁrmed in each extract by IR spectra
and HPLC-UV-DAD proﬁling using previously isolated or standard compounds. The toxicity of each
extract was evaluated in a repeated-dose toxicity study in Wistar rats for 90 days.
Results: The AE is composed of both STLs and CAs, the LRE is rich in STLs, and the PE is rich in CAs. The AE
caused alterations in haematological parameters but few alterations in biochemical parameters and was
relatively safe at doses lower than 100 mg/kg. However, the PE and LRE demonstrated several adverse
effects by damaging the liver and kidneys, respectively.
Conclusion: STLs and CAs can be toxic in prolonged use at higher doses in extracts prepared from Tithonia
diversifolia by affecting the kidneys and liver.
& 2013 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
Tithonia diversifolia (Hemsl.) A. Gray is a shrub in the Asteraceae
family native to Mexico and Central America (Játem-Lásser et al.,
1998). Recently, this species has been identiﬁed as an invasive plant
in several countries including Brazil and regions of Asia and Africa
(Chagas-Paula et al., 2012). This species is used in folk medicine by
many different ethnic groups in different continents. In American
herbal traditional medicine, for example, Tithonia diversifolia extracts
stems and leaves are consumed orally to treat abscesses and are
applied topically to treat hematomas and muscular cramps (Chagas-
Paula et al., 2012; Frei et al., 1998; Heinrich et al. 1998, Játem-Lásser
et al., 1998). In other world regions, Tithonia diversifolia is consumedx: þ55 16 3602 4879.
ta).
.
der the Elsevier OA license.orally to treat microbiological infections, snake bites, malaria and
diabetes (Chagas-Paula et al., 2012; Liasu and Ayandele, 2008; Miura
et al., 2005; Owuor and Kisangau, 2006).
The effectiveness of the traditional uses of Tithonia diversifolia
has been conﬁrmed by various in vivo and in vitro assays. The anti-
inﬂammatory and analgesic effects of Tithonia species were demon-
strated in standard in vivo oral and topical assays (Chagas-Paula
et al., 2011; Owoyele et al., 2004). The results showed that extracts
from the leaves of Tithonia diversifolia effectively reduced inﬂam-
mation in both acute and chronic applications (Owoyele et al.,
2004). This result provides scientiﬁc basis for the use of Tithonia
diversifolia extracts for the treatment of wounds and other inﬂam-
matory diseases, as suggested in the ethnobotanical uses. Addition-
ally, the anti-malarial activity of Tithonia diversifolia was conﬁrmed
in in vitro and in vivo tests against different Plasmodium falciparum
strains (Eluﬁoye and Agbedahunsi, 2004; Oyewole et al., 2008).
However, the effective dose of the extract was observed only after
prolonged administrations, which resulted in a low mean survival
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These ﬁndings indicate the toxicity of Tithonia diversifolia in long-
term oral administrations by the population.
Acute, short-term in vivo toxicity studies have been performed
with different animals and with different modes of administration
of plant extracts (Adebayo et al., 2009; Chagas-Paula et al., 2012;
Fankule and Abatan, 2007; Oyewole et al., 2007). At 400 mg/kg, an
increase in hepatic enzyme was observed, which indicates hepa-
tocellular and kidney damage (Fankule and Abatan, 2007). How-
ever, the long-term toxicity of the aqueous extract has not been
evaluated. Additionally, no studies have investigated the chemical
compounds responsible for the toxicity of Tithonia diversifolia.
Many classes of secondary metabolites have been isolated from
the Tithonia diversifolia extracts, including diterpenoids, ﬂavo-
noids, sesquiterpene lactones (STLs) and chlorogenic acids deriva-
tives (CAs) (Ambrosio et al., 2008; Chagas-Paula et al., 2011;
Kuroda et al., 2007; La Duke, 1982). Further minor classes, such
as phytosterols, xanthanes, coumarins, ceramides, chromones and
chromenes, have also been isolated (Bouberte et al., 2006; Ragasa
et al., 2007). The anti-inﬂammatory activity of this species has
been attributed to both STLs and CAs present in the leaf extracts
(Chagas-Paula et al., 2011), while the anti-malarial activity has
been attributed mainly to STLs. The most abundant sub-class of
terpenoid present in Tithonia diversifolia consists of the STLs,
where the tagitinins are the most studied. The tagitinins A,
C and F from the foliar surface of a Brazilian population of Tithonia
diversifolia has been identiﬁed as the major constituents of the
glandular trichomes; however, tagitinin C was the major com-
pound observed in two studies performed in our laboratory
(Ambrosio et al., 2008; Chagas-Paula et al., 2011). In extracts from
leaves without trichomes, the major compounds were CAs, includ-
ing 5-O-(E)-caffeoylquinic acid (Chagas-Paula et al., 2011).
According to previous reports about the toxic activity of STLs
(Schmidt, 1999), the adverse effects of Tithonia diversifolia are
attributed to this class of compound. However, none of the studies
were able to accurately identify the toxicological mechanism of
this plant. Thus, this work aimed to analyse the long-term toxicity
of an aqueous extract of Tithonia diversifolia leaves and compare its
toxicity with an extract rich in STLs and an extract rich in CAs.
These comparisons will allow us to determine whether the
aqueous extract, which is the main preparation used in medicine,
is toxic and whether STLs are the only toxic compounds in Tithonia
diversifolia leaves.2. Materials and methods
2.1. Plant material
Leaves from Tithonia diversifolia were collected by D.A. Chagas-
Paula in April 2008 in Ribeirão Preto, SP, Brazil (S 21110.681′; W
047151.541′; altitude 538 m). A voucher specimen (R. B. Oliveira
497) was deposited in the herbarium SPFR of Universidade de São
Paulo, SP, Brazil. The entire leaves were air dried at 40 1C for a
week and stored in humidity- and light-free conditions.
2.2. Extracts preparation
The extracts were prepared as previously described (Chagas-
Paula et al., 2011). Brieﬂy, an aqueous extract (AE) was prepared as
an infusion from 350 g of powdered dried leaves in boiling
distilled water (1:10, w/v) for 20 min. The extract was ﬁltered
using common ﬁlter paper and lyophilised (yielded 23.8 g). A leaf-
rinse extract (LRE) was obtained from 3 kg of entire dried leaves
individually rinsed for 20 min in acetone. The obtained extract was
ﬁltered, and the solvent was evaporated under reduced pressure.The dry residue was resuspended in 10 mL of MeOH:H2O (7:3, v/v)
to precipitate fatty material. The supernatant was evaporated
under vacuum and lyophilised (yielded 27 g of residue). This
procedure promotes preferential extraction of STLs in glandular
trichomes on the surface of the leaves. A polar extract (PE) was
prepared using 200 g of dried leaves previously rinsed with
acetone (without trichomes), which were further macerated at
room temperature with MeOH:H2O (7:3, v/v) for three days; the
solvent was changed every 24 h. The obtained extract was ﬁltered
and partitioned with n-hexane. The hydromethanolic fraction was
evaporated under reduced pressure and lyophilised (yielded 25.4 g
of residue). All lyophilised material was stored at −20 1C until
analysis.
2.3. Phytochemical analysis
Phytochemical analyses and the quantiﬁcation of the major
components of the plant were performed according to previously
published by our group (Chagas-Paula et al., 2011), which brieﬂy
consisted in the analyses of the three extracts by infrared (IR)
spectroscopy and HPLC-UV-DAD. The IR measurements were per-
formed with samples prepared in KBr pellets using a Perkin Elmer
RX-ISTIR System spectrometer (USA). The identiﬁcation of the main
classes of compounds was based on UV data, and the identiﬁcation of
speciﬁc constituents was performed by comparisons of the UV data
and retention times with data from authentic standards available in
our laboratory (Ambrosio et al., 2008). Quantiﬁcations were per-
formed using a standard curve of tagitinin C for STLs, 5-O-(E)-
caffeoylquinic for CAs and luteolin for ﬂavonoids. These compounds
were solubilised in a stock solution of 1:1 MeCN:H2O containing
ﬂavone as an internal standard. The analyses were performed in
duplicate by an automatic injector in serial concentrations: tagitinin
C from 2000 μg/mL to 1 μg/mL, 5-O-(E)-caffeoylquinic acid from
500 μg/mL to 0.25 μg/mL and luteolin from 250 μg/mL to 0.5 μg/mL.
Tagitinin C and luteolin were analysed at 254 nm, and
5-O-(E)-caffeoylquinic acid was analysed at 325 nm. The HPLC-UV-
DAD system consisted of a Shimadzu liquid chromatograph (LC-10
Avp pumps, SCL-10 Avp controller, SPD-10 Avp diode array detector-
DAD, and software Class VP, version 5.02, Japan) using two C-18 Onix
monolithic columns (3100 mm; Phenomenex, USA) coupled in
series with a ﬂow rate of 1.2 mL/min and the following gradient
elution: MeCN 0.1% AcOH (B)–H2O 0.1% AcOH (A); 0–35 min 0–25% B
(linear gradient), 35–60 min 25% B (isocratic gradient) and 5 min
100% B. The UV chromatograms were recorded at 215 nm, 254 nm
and 325 nm.
2.4. Animals
In this study, male and female Wistar rats (200–250 g) from the
animal house of the campus of the Universidade de São Paulo,
Ribeirão Preto, SP were used. Animals were maintained at a
temperature of 2572 1C with a 12 h dark/light cycle and free
access to food and water. The study was approved by the Institu-
tional Ethical Animal Committee of the Universidade de São Paulo
(protocol number 08.1.227.53.2), according to the rules of the
Brazilian Committee for Animal Care (COBEA).
2.5. Repeated-dose toxicity study
Wistar rats were divided into eight groups of six animals per
group. Control or treated groups received through a gastric gavage
the vehicle (Cremophor® EL 5% Basf, Germany) or extracts, respec-
tively, and in all cases the dosage volume did not exceed 1 mL.
Treated groups were administered at 10 mg/kg and 100 mg/kg
of the AE and PE, and 10 mg/kg and 50 mg/kg of the LRE, all for
90 days. Body weights and food intake were measured weekly, and
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observed and any signs of abnormality were recorded; also body
weight and food intake were measured weekly. After 12 h of fasting,
the animals were anaesthetised (xylazine and ketamine 1:1 v/v,
1 μL/g of the body weight), and blood was collected using cardiac
puncture. For the haematological analyses, the total and differential
(%) leukocytes (neutrophils, lymphocytes, monocytes, eosinophils
and basophils) and erythrocytes were measured. The haematologi-
cal analyses were performed manually in a Neubauer chamber
for the total leukocyte (diluted in Turk solution) and erythrocyte
counts (diluted in saline solution). Blood smears stained with
Panotic® solution (Laborclin, Brazil) were used to perform differ-
ential leukocyte count. The biochemical analyses of the plasma
(glucose) and serum samples were performed using an automatic
chemistry analyser (ABBA VP, Abott®, USA) and commercial kits
for biochemical analyses (Labtest, Brazil). The following biochemical
parameters were measured: uric acid, albumin, alanine amino-
transferase (ALT), aspartate aminotransferase (AST), alkaline phos-
phatase (ALP), cholesterol, triglyceride, total protein, creatinine and
glucose.
After blood collection, the animals were euthanised by decap-
itation followed by necropsy. The internal organs were observed
for any sign of lesions and weighed to determine relative organ
weights. Small pieces were ﬁxed in 10% buffered formaldehyde
solution for 48 h and processed for histopathological studies. The
organ pieces were dehydrated with an increasing alcohol grade
(70, 80, 90, 95% and absolute), further cleared in xylene and
embedded in parafﬁn. Micrometre sections were stained with
haematoxylin and eosin and examined under a light microscope,
and photomicrographs of the samples were recorded.
2.6. Statistical analysis
For the analysis of the biochemical parameters, the data were
expressed as the mean7S.E.M, and the treated and control groups
were compared using one-way analysis of variance (ANOVA)
followed by Dunnett's test. The statistical treatments for weight
increase and water and food intake were performed by two-way
ANOVA followed by the Bonferroni's test. In all the analyses, a 95%
conﬁdence level was used to determine statistically signiﬁcant
differences between the treated and control groups.3. Results
3.1. Phytochemical analysis
The chemical composition of three extracts obtained in this
study has been published recently by our research group (Chagas-
Paula et al., 2011). Brieﬂy, it was demonstrated that the LRE is rich
in STLs as shown by the typical strong band of carbonyl stretching
of the γ-lactones at 1760 cm−1 in IR spectrum and the UV
absorption of the major compounds between 210 nm and
220 nm observed during HPLC-UV-DAD analyses. Comparisons
with authentic samples and the quantiﬁcation procedure showed
that tagitinin C was the major constituent of the STLs at a
concentration of 479.39 μg/mg LRE. Some ﬂavonoids were also
present in the LRE as indicated by their typical UV spectra. The
ﬂavonoid luteolin was present at a concentration of 5.10 μg/mg LRE.
In the PE, STLs were undetectable in both IR and HPLC-UV-DAD
analysis. The PE contains polar compounds with peaks that appear in
the beginning of the chromatogram until 30 min with UV spectra
characteristic of CAs (UVmax at approximately 298 nm and 325 nm).
The CA 5-O-(E)-caffeoylquinic acid was present at a concentration of
39.08 μg/mg PE. The AE contained both STLs and CAs. The quantiﬁca-
tion demonstrated that the 5-O-(E)-caffeoylquinic acid was present ata concentration of 8.02 μg/mg AE, while tagitinin C was present at a
very low concentration of 3.13 μg/mg AE.3.2. Repeated-dose toxicity study
3.2.1. Haematological and biochemical alterations
The AE did not alter the erythrocyte count at both doses. The PE
at a concentration of 100 mg/kg (7.370.50 million cells/mm3) and
the LRE at both doses (7.6970.27 cells/mm3 at 10 mg/kg and
6.9570.31 cells/mm3 at 50 mg/kg) caused an increased number of
erythrocytes compared with the control group (5.1770.45 cells/
mm3) (Fig. 1). The total white blood cell (WBC) count was
statistically lower at both tested doses of the AE (29827544.8
cells/mm3 at 10 mg/kg and 23547509.6 cells/mm3 at 100 mg/kg)
and at 50 mg/kg of the LRE (32207360.3 cells/mm3) compared
with the control (54387904.4 cells/mm3). The PE caused no
signiﬁcant differences in the WBC count. All the extracts caused
decreases in the percentage of neutrophils (Fig. 1). The AE
decreased the percentage of neutrophils at both doses, while only
the highest doses (100 mg/kg of the PE and 50 mg/kg of the LRE) of
the PE and LRE caused statistically signiﬁcant differences. Simi-
larly, the AE caused an increase in the percentage of mononuclear
cells at both doses, while the PE and LRE only caused increases at
the highest doses (Fig. 1). No other extracts caused signiﬁcant
differences in the eosinophil or basophil counts compared with
the control (data not shown).
The AE administration only affected two of the biochemical
parameters analysed (Fig. 2). The animals treated with the AE at a
concentration of 100 mg/kg demonstrated increased levels of AST
(161.60710.03 U/L) compared with the control animals (111.67
10.03 U/L). Animals treated at both doses of the AE demonstrated
decreased levels of ALP (51.1374.16 U/L at 10 mg/kg and
57.1277.71 U/L at 100 mg/kg, control 92.72712.30 U/L). None of
the extracts caused signiﬁcant differences in the cholesterol count
compared with the control (data not show).
The PE administration caused signiﬁcant alterations of several
biochemical parameters (Fig. 2). Signiﬁcantly decreased levels of
ALT (12. 2276.19 U/L at 100 mg/kg, control 46.1172.67 at 100 U/L)
and AST (10.6271.81 U/L at 100 mg/kg, control 116.677.80 U/L)
were observed. Increased levels of ALP (141.10715.15 U/L at
10 mg/kg, control 92.72712.30 U/L), triglycerides (109.475.45
mg/dL at 10 mg/kg, 137.7718.87 mg/dL at 100 mg/kg, control
36.33714.94 mg/dL), albumin (3.8070.08 g/dL at 10 mg/kg,
3.8171.02 g/dL at 100 mg/kg, control 2.7170.09 g/dL), total pro-
teins (12.2670.17 g/dL at 10 mg/kg, 21.3271.05 g/dL at 100 mg/kg,
control 8.5970.16 g/dL), creatinine (0.9270.12 mg/dL at 10 mg/kg,
1.1970.08 mg/dL at 100 mg/kg, control 0.8070.05 mg/dL), uric
acid (4.8971.27 mg/dL at 100 mg/kg, control 1.5270.14 mg/dL)
and glucose (238.7713.97 mg/dL at 10 mg/kg, control 143.17
27.42 mg/dL) were observed.
The animals that received the LRE treatment demonstrated
signiﬁcantly decreased levels of ALT (18.2772.87 U/L at 50 mg/kg,
control 46.1172.68 U/L) and total proteins (5.3670.01 g/dL at
50 mg/kg, control 8.5870.16 g/dL). Increased levels of ALP
(150.976.37 U/L at 10 mg/kg, 162.4712.01 U/L at 50 mg/kg, con-
trol 92.72712.30 U/L), triglycerides (186.3712.75 mg/dL at
50 mg/kg, control 36.33714.94 mg/dL), creatinine (1.0870.17
mg/dL at 10 mg/kg, 0.9970.14 mg/dL at 50 mg/kg, control 0.807
0.05 mg/dL) and glucose (193.1710.20 mg/dL at 10 mg/kg, 154.37
6.99 mg/dL at 50 mg/kg, control 143.1722.42 mg/dL) were
observed. The levels of albumin and AST increased at the lower
dose and decreased at the higher dose: albumin (3.5670.11
g/dL at 10 mg/kg, 1.9870.05 g/dL at 50 mg/kg, control 2.7170.09
g/dL), AST (154.5716.55 U/L at 10 mg/kg, 1.9870.05 U/L at 10 mg/
kg, control 116.677.80 U/L).
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Fig. 2. Effects of oral administration of Tithonia diversifolia extracts (AE, PE and LRE) on biochemical parameters. Data are expressed as the mean7S.E.M., n¼6. The
experimental results of different treatments were analysed using analysis of variance (ANOVA) followed by Dunnett's test for comparison with the control group. *Po0.05
compared with the control group.
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Fig. 1. Effects of oral administration of Tithonia diversifolia extracts (AE, PE and LRE) on haematological parameters. Data are expressed as the mean7S.E.M, n¼6. The
experimental results of the different treatments were analysed using analysis of variance (ANOVA) followed by Dunnett's test for comparison with the control group.
*Po0.05 compared with the control group.
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Increases in the weights of the thymus, spleen and kidneys
were observed in the animals treated with the LRE at 100 mg/kg
compared with the control group (Table 1). The animals treated
with 10 mg/kg of the AE demonstrated decreased liver weights,
but no statistically signiﬁcant alterations were observed in the
animals treated with the PE.
The liver histology of the animals treated with the AE and LRE
were not signiﬁcantly altered, while the livers of animals treated
with the PE showed degenerative hepatocytes with serious dis-
ruption of sinusoids caused by a steatosis (Fig. 3). The kidney
histology of the animals treated with the AE and PE was relatively
normal, but serious alterations in the glomerular and tubular
shapes were observed. The glomeruli demonstrated atrophy and
degeneration of the mesangial matrix with amorphous material
deposited in the tubules (Fig. 3).Table 1
Organs weight of treated animals with the three extracts (AE, PE and LRE) of
Tithonia diversifolia leaves compared with the controls.
Group Thymus (g) Liver (g) Spleen (g) Kidney
Control 2.1970.37 29.3371.80 2.0470.15 3.8370.19
AE 10 mg/kg 2.1470.16 23.6770.94n 2.1670.12 3.4770.16
AE 100 mg/kg 1.6470.23 31.1071.54 2.3070.10 3.9170.24
PE 10 mg/kg 1.1770.11 26.5971.56 2.2370.09 3.6670.12
PE 100 mg/kg 1.4470.25 31.3672.09 2.0170.15 4.0870.23
LRE 10 mg/kg 1.1870.07 25.6370.93 2.2270.17 3.4770.07
LRE 100 mg/kg 3.9870.60n 33.3170.75 2.7470.17n 4.9870.17n
Value are expressed as the mean7S.E.M., n¼6. The experimental results of the
different treatments were analysed using analysis of variance (ANOVA) followed by
Dunnett's test for comparison with the control group.
n Po0.05 compared with the control group.
Fig. 3. Photomicrographs of the livers and kidneys of animals treated with different extra
100 mg/kg; no signiﬁcant histological alterations were observed. (B) Liver of animal treate
of animal treated with the AE at 100 mg/kg; no signiﬁcant histological alterations were o
glomeruli and amorphous material deposited in the distal tubules of the cortical region4. Discussion
In the present study, the 90-day toxicity of an aqueous extract
(AE) prepared from an infusion of Tithonia diversifolia leaves was
evaluated. In popular medicine, the aqueous extract is the most
commonly used preparation (Heinrich et al., 1998). The phyto-
chemical analysis demonstrated that the AE of Tithonia diversifolia
contains both STLs and CAs. STLs have been reported to be toxic in
previous studies (Schmidt, 1999), while CAs are relatively safe and
are present in some vegetables consumed in the human diet (Zhao
and Moghadasian, 2010). The AE at a dose of 10 mg/kg caused
alterations in haematological parameters and alkaline phospha-
tase. The haematological alterations were characterised by
decreased counts of total leukocytes and neutrophils. These effects
may be related to the anti-inﬂammatory activities attributed to the
plant. The AE inhibited neutrophil migration to the inﬂammation
site in a recent study (Chagas-Paula et al., 2011). The ALP levels
decreased, but the toxicological relevance of this decrease has not
been reported in the literature. The AE at a dose of 100 mg/kg
caused the same haematological alterations along with increased
AST levels, which indicated hepatic damage. However, in the liver
histological analyses, no signiﬁcant alterations were observed.
Adebayo et al. (2009) tested an aqueous extract via oral adminis-
tration in Wistar rats at 100 and 200 mg/kg for seven days. In that
study, the extract caused no alterations at 100 mg/kg in the
haematological and biochemical parameters analysed by the
authors. However, at 200 mg/kg, the alkaline phosphatase levels
increased in the liver and heart, demonstrated the toxicity of the
aqueous extract at this concentration.
In another study, an aqueous extract of Tithonia diversifolia
administered orally at 100 mg/kg, 200 mg/kg or 400 mg/kg
for 14 days caused signiﬁcant toxicity including changes incts (AE, PE and LRE) of Tithonia diversifolia. (A) Liver of animal treated with the AE at
d with the PE at 100 mg/kg; steatosis was observed in the hepatic tissue. (C) Kidney
bserved. (D) Kidney of animal treated with the LRE at 50 mg/kg; degeneration of the
were observed.
F.D. Passoni et al. / Journal of Ethnopharmacology 147 (2013) 389–394394haematological, biochemical and histopathological parameters in
Wistar rats (Fankule and Abatan, 2007). Statistically signiﬁcant
reductions in the packed cell volume, haemoglobin and erythro-
cytes at 200 mg/kg and increased mean corpuscular volume and
mean corpuscular haemoglobin concentration at 400 mg/kg
suggested that Tithonia diversifolia may cause macrocytic hyper-
chromic anaemia, which is normally reversible. At 400 mg/kg, the
ALP, ALT, albumin, total bilirubin and total protein increased
signiﬁcantly, whereas at 100 mg/kg, only the AST increased sig-
niﬁcantly. The increase in hepatic enzyme levels may indicate
hepatocellular damage, which was further conﬁrmed by the
increase in total bilirubin and histopathological lesions of multi-
focal vacuolar degeneration necrosis and the thinning of the
hepatic cord in the centrilobular region. The increases in albumin
and total protein explain the marked congestion of the renal
capillaries with diffuse degeneration and necrosis of the tubular
epithelium along with a focal area of perivascular lymphocytic
inﬁltration on the kidney. Glucose, triglycerides and urea main-
tained normal levels at all the doses (Fankule and Abatan, 2007).
Thus, the aqueous extracts prepared from Tithonia diversifolia
leaves can be toxic at doses up to 100 mg/kg in rats with
alterations mainly in the liver and kidneys.
To identify the compounds (STLs or CAs) responsible for the
toxic effects of the AE, we prepared one extract rich in STLs (LRE)
and one extract (PE) rich in CAs and without STLs. The animals
treated with the PE at 10 mg/kg and 100 mg/kg for 90 days
displayed alterations in the levels of several haematological and
biochemical parameters, including erythrocytes, AST, ALT, alkaline
phosphatase, triglycerides, albumin, total proteins, creatinine and
glucose. Histological analysis demonstrated serious steatosis in the
liver especially at the higher dose (100 mg/kg) and no signiﬁcant
alterations in the kidneys.
The animals treated with the LRE demonstrated serious com-
partmental signs of toxicity including dyspnoea and asthenia
during some days of treatment. Thus, these animals were treated
with the LRE only for 14 days. Blood was collected and animals
were euthanised immediately after this period for haematological,
biochemical and histopathological studies. The animals treated
with the LRE at 10 mg/kg and 50 mg/kg demonstrated alterations
in erythrocytes, AST, alkaline phosphatase, albumin, triglycerides,
total proteins, creatinine and glucose. The histological analyses
demonstrated damage in the kidneys of these animals with more
serious lesions at 50 mg/kg, including destruction of glomeruli and
distal tubules. The same results were reported in another study
using an extract rich in STLs from Smallanthus sonchifolius (Poepp.)
H. Rob. (Asteraceae) leaves (Oliveira et al., 2011). Both studies
conﬁrmed that STLs are toxic when ingested and raise concerns
about the ingestion of teas prepared from STL-containing medic-
inal plants.5. Conclusions
STLs and CAs are present in the aqueous extract of Tithonia
diversifolia leaves. The CAs are more concentrated than the STLs in
the aqueous extract preparation. The aqueous extracts at doses of
10 mg/kg and 100 mg/kg administered for 90 days to rats were
relatively safe with some toxicity observed at 100 mg/kg. Studies
by other authors demonstrated that the aqueous extract adminis-
tered at doses up to 100 mg/kg can cause damage to the liver,
kidneys and, to a lesser extent, the heart. Our results demonstrated
that extracts with higher concentrations of CAs can cause liver
injuries, while extracts rich in STLs can cause kidney damage.Thus, the liver injury observed at higher doses of aqueous extracts
of Tithonia diversifolia may result from the CAs, while kidney
damage results from the STLs.Acknowledgements
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